文献速递白血病造血干细胞移植与细胞治疗

靶向细胞内Wilms瘤1抗原的优化T细胞受体模拟嵌合抗原受体T细胞

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen.
PubMed 文献 · Leukemia · 2016-12-07

本文报道一种名为WT1-28z的T细胞受体模拟(TCRm)嵌合抗原受体(CAR),可识别以HLA-A*02:01限制性方式呈递在肿瘤细胞表面的细胞内癌蛋白Wilms瘤1(WT1)肽段。表达WT1-28z的T细胞可特异性靶向并裂解HLA-A*02:01+ WT1+肿瘤,并延长植入HLA-A*02:01+、WT1+白血病或卵巢肿瘤小鼠的生存期。该体内功能验证为将免疫治疗靶点扩展至有吸引力的细胞内靶点提供了概念验证。

要点

  • WT1-28z为靶向细胞内WT1的T细胞受体模拟CAR,识别HLA-A*02:01呈递的WT1肽段。
  • WT1-28z T细胞可特异性靶向并裂解HLA-A*02:01+ WT1+肿瘤。
  • WT1-28z T细胞延长植入HLA-A*02:01+、WT1+白血病或卵巢肿瘤小鼠的生存期。

核心结论

  • TCRm CAR T细胞的体内功能验证为将免疫治疗可有效靶向的肿瘤相关抗原范围扩展至有吸引力的细胞内靶点提供了概念验证,并可能对扩展CAR T细胞治疗的成功具有巨大潜力。

研究设计与样本

  • 本研究报道一种名为WT1-28z的T细胞受体模拟CAR,反应于细胞内癌蛋白Wilms瘤1(WT1)的肽段部分,该肽段以HLA-A*02:01限制性方式表达于肿瘤细胞表面。
  • 研究在植入HLA-A*02:01+、WT1+白血病或卵巢肿瘤的小鼠中进行体内功能验证。

主要发现

  • 表达WT1-28z的T细胞可特异性靶向并裂解HLA-A*02:01+ WT1+肿瘤。
  • 表达WT1-28z的T细胞增强植入HLA-A*02:01+、WT1+白血病或卵巢肿瘤小鼠的生存。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CD19-directed chimeric antigen receptor (CAR) T cells are clinically effective in a limited set of leukemia patients. However, CAR T-cell therapy thus far has been largely restricted to targeting extracellular tumor-associated antigens (TAA). Herein, we report a T-cell receptor-mimic (TCRm) CAR, termed WT1-28z, that is reactive to a peptide portion of the intracellular onco-protein Wilms Tumor 1(WT1), as it is expressed on the surface of the tumor cell in the context of HLA-A*02:01. T cells modified to express WT1-28z specifically targeted and lysed HLA-A*02:01+ WT1+ tumors and enhanced survival of mice engrafted with HLA-A*02:01+, WT1+ leukemia or ovarian tumors. This in vivo functional validation of TCRm CAR T cells provides the proof-of-concept necessary to expand the range of TAA that can be effectively targeted for immunotherapy to include attractive intracellular targets, and may hold great potential to expand on the success of CAR T-cell therapy.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Rafiq S, Purdon TJ, Daniyan AF, et al. Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen. Leukemia. 2016. PMID: 27924074. doi:10.1038/leu.2016.373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。